No Data
No Data
LifeMD, Inc. (LFMD): A Bull Case Theory
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
Lake Street Sticks to Its Buy Rating for LifeMD (LFMD)
KeyBanc Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $7
Lifemd Announces Expanded Acceptance Of Insurance To Medicare Beneficiaries For Qualifying Care
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in Its Weight Loss Programs
loading...
NAN_BULL : May I ask at what age you semi-retired?
JST_ : awesome! thanks for sharing![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
JoeskiTheRookie : good luck to you.
韩寒就是好的北京市开 :
like your post real life .. I'm also in the same shoe 
72655275 : Wishing you good luck.
View more comments...